Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Although most individuals recover from acute SARS-CoV-2 infection, a significant number continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the unexplained symptoms that are frequently referred to as long COVID, which could last for weeks, months, or even years after the acut...

Descrizione completa

Dettagli Bibliografici
Autori principali: Hector Bonilla, Michael J. Peluso, Kathleen Rodgers, Judith A. Aberg, Thomas F. Patterson, Robert Tamburro, Lawrence Baizer, Jason D. Goldman, Nadine Rouphael, Amelia Deitchman, Jeffrey Fine, Paul Fontelo, Arthur Y. Kim, Gwendolyn Shaw, Jeran Stratford, Patricia Ceger, Maged M. Costantine, Liza Fisher, Lisa O’Brien, Christine Maughan, John G. Quigley, Vilma Gabbay, Sindhu Mohandas, David Williams, Grace A. McComsey
Natura: Articolo
Lingua:English
Pubblicazione: Frontiers Media S.A. 2023-03-01
Serie:Frontiers in Immunology
Soggetti:
post-acute sequela of SARS-CoV-2 (PASC)
long COVID
SARS- CoV-2
long haulers
treatment
clinical trials
Accesso online:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129459/full

Accesso online

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129459/full

Documenti analoghi